Communiqués LataMed AI Corp.

Actions

LMED.D

US21116R4048

Equipements électroniques de bureau

Marché Fermé - OTC Markets Autres places de cotation 21:59:06 27/07/2026			Varia. 5j.	Varia. 1 janv.
0,5403 ^USD	-22,81%		-53,82%	+315,62%

23/07	LataMed AI Corp., via sa filiale LATAMEDAI VE, et FARMASER concluent un protocole d'accord pour le développement d'une plateforme d'automatisation des opérations pharmaceutiques	CI
20/07	LataMed AI Corp fait progresser son initiative de télémédecine industrielle pour les opérations isolées et offshore au Venezuela	CI

Communiqués

15/07	LataMed AI Corp. Announces Effectiveness of 5-for-1 Forward Stock Split	EQ
13/07	LataMed AI Begins Evaluating Global Healthcare Expansion Opportunities Through Planned Attendance at World Health Expo 2027	EQ
09/07	LataMed AI Chief Executive Officer Dr. Kevin Rodan to Be Recognized by Ministry of Health for Healthcare Innovation	EQ
08/07	LataMed AI Provides Shareholder Update Regarding Upcoming 5-for-1 Forward Stock Split and Mandatory Share Exchange Process	EQ
06/07	LataMed AI Begins Planned Expansion Into Colombia Through Initial Due Diligence and Strategic Planning	EQ
01/07	LataMed AI Executes Strategic Commercial Alliance With Telecom Provider to Expand Digital Healthcare Accessibility Across Venezuela	EQ
30/06	LataMed AI Executes Strategic Commercial Alliance With Vrtice Seguros to Expand Digital Healthcare and Insurance Ecosystem	EQ
24/06	LataMed AI Advances Wellness Market Expansion Strategy Through Strategic Agreement With Focus Fitness	EQ
23/06	LataMed AI Expands Healthcare Industry Visibility Through Upcoming ES Salud Magazine Feature	EQ
17/06	LataMed AI Highlights Key Industry Insights and Strategic Engagements Following Attendance at HLTH Europe 2026	EQ
15/06	LataMed AI Expands Healthcare Ecosystem Through Strategic Evaluation With Vertice Seguros	EQ
11/06	LataMed AI Initiates Strategic Process to Evaluate Installment-Based Healthcare Payment Integration With Cashea Platform	EQ
09/06	LataMed AI Evaluates Expansion of Strategic Growth Initiative Into Fitness and Wellness Markets Through Planned AI Health Agent Deployment	EQ
05/06	LataMed AI Announces Academic Collaboration With Universidad Central de Venezuela Faculty of Medicine	EQ
02/06	LataMed AI Finalizing Exclusive Live-Streamed Media Interview to Present Digital Healthcare Strategy, Technology Initiatives, and Latin America Growth Vision	EQ
28/05	LataMed AI Corp. to Attend MEDICA 2026 in Germany as Company Advances Innovative Healthcare Technology Strategy	EQ
26/05	LataMed AI Announces AI-Powered Pharmacy Fulfillment Initiative With Venezuelan Pharmacy Operators	EQ
22/05	LataMed AI Advances Development of Mobile Healthcare Applications for Apple App Store and Google Play; Early Platform Subscribers Surpass 1,000	EQ
19/05	LataMed AI Highlights Planned Emergency Medical Response Feature Within Telehealth Platform Infrastructure	EQ
14/05	LataMed AI to Submit Forward Stock Split Request to FINRA as Company Advances Operational Expansion Strategy	EQ
12/05	LataMed AI Corp. to Attend Meditech Colombia 2026 as Company Advances Latin American Commercialization Strategy	EQ
11/05	LataMed AI Corp. to Begin Trading Under Symbol LMED Following FINRA Approval	EQ
08/05	LataMed AI Corp. Announces Expected Effectiveness of Name and Symbol Change to LMED	EQ
07/05	Catalyst Crew Technologies Provides Update on Share Cancellation Initiative and Corporate Name Change	EQ
05/05	Catalyst Crew Technologies Announces Receipt of Venezuelan Health Authority Approval for Telehealth Platform Operations	EQ